Autologous islet cell therapy (Shanghai Zhongshan Hospital)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameAutologous islet cell therapy (Shanghai Zhongshan Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Zhongshan Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Zhongshan Hospital
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A